@article{73e74f78d21149e2973df6893bfc1853,
title = "Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study",
keywords = "cardiac toxicity, cardiotoxicity, colorectal cancer, fluoropyrimidines, gastrointestinal cancer, S-1, 3122 Cancers",
author = "P. Osterlund and S. Kinos and P. Pfeiffer and T. Salminen and Kwakman, {J. J.M.} and Fr{\"o}din, {J. E.} and Shah, {C. H.} and H. Sorbye and R. Ristam{\"a}ki and P. Halonen and Soveri, {L. M.} and E. Heerv{\"a} and A. {\AA}lgars and M. B{\"a}rlund and H. Hagman and R. McDermott and M. O'Reilly and R. R{\"o}ckert and G. Liposits and R. Kallio and P. Flygare and Teske, {A. J.} and {van Werkhoven}, E. and Punt, {C. J.A.} and B. Glimelius",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s)",
year = "2022",
month = jun,
doi = "10.1016/j.esmoop.2022.100427",
language = "English",
volume = "7",
journal = "ESMO open",
issn = "2059-7029",
publisher = "BMJ Publishing Group Ltd",
number = "3",
}